Retrospective Clinical Study With Clalit

As part of the Nervio/Clalit collaboration, Nervio has received 500,000 biosignals which are going to be used for building elaborate AI models and performing retrospective trials using the given data.

With more than 48 thousand doctors and employees, 14 hospitals, and 4 subsidiaries, Clalit is the largest HMO in Israel and the 2nd largest healthcare provider in the world. Clalit provides services to more than 50% of the country’s population.